Acute Effects of Green Tea Intake on Countermovement Jump and Cognitive Performance in Taekwondo Athletes (green-tea)

November 8, 2026 updated by: Halil UÇAR, Inonu University

Acute Effects of Green Tea Intake on Countermovement Jump and Cognitive Performance in Taekwondo Athletes: A Randomized, Placebo-Controlled Crossover Trial

This study aims to investigate the acute effects of green tea intake on countermovement jump performance and cognitive performance in male Taekwondo athletes. A randomized, placebo-controlled, three-condition crossover design will be used. Each participant will complete control, placebo, and green tea conditions in a randomized and counterbalanced order, with a washout period of at least 72 hours between sessions. CMJ performance will be assessed as the primary outcome, followed by the Stroop test as the secondary outcome.

Study Overview

Status

Not yet recruiting

Conditions

Intervention / Treatment

Detailed Description

Following a familiarization session, participants will complete three experimental sessions. At the beginning of each session, body weight will be measured. Participants will then receive the assigned condition and wait for 60 minutes. After a standardized warm-up, CMJ performance will be assessed using the My Jump Lab application. Following a 5-minute standardized rest period, cognitive performance will be evaluated using the Stroop test. The order of experimental conditions will be randomized and counterbalanced among participants.

Study Type

Interventional

Enrollment (Estimated)

27

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 25 years (Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Male

Description

Inclusion Criteria:

Healthy male Taekwondo athletes aged 18-25 years.

At least 3 years of licensed Taekwondo experience.

Regular Taekwondo training at least 3 days per week during the previous 6 months.

Willingness to participate voluntarily and provide written informed consent.

Exclusion Criteria:

Presence of any chronic disease.

Cardiovascular, metabolic, or neurological disorders.

Lower-extremity injury or surgery within the previous 6 months.

Regular medication use.

Known sensitivity to caffeine or green tea.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Control

Participants will complete the control condition without receiving green tea or placebo.

Participants will not receive green tea extract or placebo during the control condition. They will follow the same experimental procedures and assessment schedule as in the other conditions, including a 60-minute waiting period before the standardized warm-up and performance assessments.

Placebo Comparator: Placebo

Participants will receive a placebo preparation

Participants will receive a placebo orally 60 minutes before the performance assessments.

Experimental: Green Tea

Participants will receive a standardized green tea extract preparation.

Participants will receive green tea extract orally 60 minutes before the performance assessments. The intervention will be administered according to the study protocol.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Countermovement Jump (CMJ) Performance
Time Frame: Immediately after the 5-minute rest period following the CMJ assessment.

Cognitive performance will be assessed using the Stroop test. Performance will be evaluated based on reaction time and accuracy.

Immediately after the 5-minute rest period following the CMJ assessment.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Cognitive Performance Assessed by the Stroop Test
Time Frame: Immediately after the 5-minute rest period following the CMJ assessment.

Cognitive performance will be assessed using the Stroop test. Reaction time and accuracy (number of correct responses and errors) will be recorded.

Immediately after the 5-minute rest period following the CMJ assessment.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Collaborators

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

November 1, 2026

Primary Completion (Estimated)

December 1, 2026

Study Completion (Estimated)

December 1, 2026

Study Registration Dates

First Submitted

November 8, 2026

First Submitted That Met QC Criteria

November 8, 2026

First Posted (Actual)

November 16, 2026

Study Record Updates

Last Update Posted (Actual)

November 16, 2026

Last Update Submitted That Met QC Criteria

November 8, 2026

Last Verified

November 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • INU-ARCH-2026-25

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.